Atlas Trials

AML/MDS

7 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch AML/MDS

RecordFirmDate
Danvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed/Refractory MDS & AML (NCT05986240)Montefiore Medical Center2024-05-08
SENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDS (NCT06325748)Senti Biosciences2024-04-22
Innate Donor Effector Allogeneic Lymphocyte Infusion After Stem Cell Transplantation: the IDEAL Trial (NCT05686538)Rigshospitalet, Denmark2022-01-01
Study of Mana 312 (Multi Tumor-Associated Antigen T Cells) in Adults With AML/MDS After HSCT (NCT04679194)Mana Therapeutics2020-12-08
CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML) (NCT04318678)St. Jude Children's Research Hospital2020-07-29
Dose-Escalation Study of Oral Administration of LP-108 as Monotherapy and in Combination With Azacitidine in Patients With Relapsed or Refractory MDS, CMML, or AML (NCT04139434)Newave Pharmaceutical Inc2020-07-06
Tolerability and Efficacy of Midostaurin to 10-day Decitabine in Unfit Adult AML and High Risk MDS Patients (NCT04097470)Stichting Hemato-Oncologie voor Volwassenen Nederland2019-12-05

Track AML/MDS automatically

Every clearance here is in the API, with alerts when new ones post.